Home › Cancro al seno › California › Baldwin Park
Studi clinici su Cancro al seno a Baldwin Park, CA
44 studi su Cancro al seno cercano partecipanti presso sedi a Baldwin Park e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
In reclutamentoFase 3
- City of Hope National Medical Center, Duarte · a 4 mi di distanza
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
In reclutamentoFase 2
- City of Hope - Duarte Cancer Center, Duarte · a 4 mi di distanza
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
In reclutamentoFase 3
- City of Hope National Medical, Duarte · a 4 mi di distanza
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
In reclutamentoFase 1
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Duarte · a 4 mi di distanza
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
In reclutamentoFase 3
- City of Hope, Duarte · a 4 mi di distanza
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
In reclutamentoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
In reclutamentoFase 1/2
- City of Hope, Duarte · a 4 mi di distanza
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
In reclutamentoFase 3
- City of Hope National Medical Center, Duarte · a 4 mi di distanza
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
In reclutamentoFase 1/2
- City of Hope - Duarte, Duarte · a 4 mi di distanza
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
In reclutamentoFase 3
- Research Site, Duarte · a 4 mi di distanza
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
In reclutamentoFase 1/2
- City of Hope, Duarte · a 4 mi di distanza
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
In reclutamentoFase 1/2
- City of Hope, Duarte · a 4 mi di distanza
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
In reclutamentoFase 2
- City of Hope--Duarte, Duarte · a 4 mi di distanza
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
In reclutamento
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
In reclutamentoFase 3
- City of Hope - Duarte Cancer Center, Duarte · a 4 mi di distanza
E-Mindfulness Approaches for Living After Breast Cancer
In reclutamentoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · a 4 mi di distanza
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
In reclutamentoFase 2
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
In reclutamentoFase 4
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
In reclutamentoFase 3
- City of Hope Medical Center, Duarte · a 4 mi di distanza
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
In reclutamento
- Beckman Research Institute of City of Hope, Duarte · a 4 mi di distanza
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- City of Hope, Duarte · a 4 mi di distanza
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
In reclutamentoVolontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Duarte · a 4 mi di distanza
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
In reclutamentoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Studi su Cancro al seno in altre città
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Baldwin Park
- Leucemia mieloide acuta40 studi
- Cancro colorettale37 studi
- Cancro del polmone non a piccole cellule36 studi
- Cancro (tutti i tipi)34 studi
- Cancro alla prostata30 studi
- Cancro metastatico30 studi
- Sindromi mielodisplastiche26 studi
- Cancro ovarico25 studi
- Cancro ai polmoni24 studi
- Mieloma multiplo23 studi
- Cancro dello stomaco22 studi
- Leucemia linfoblastica acuta21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.